##################################################################################
# Document Properties
##################################################################################

SET DOCUMENT Name = "PMID_32169119"
SET DOCUMENT Authors = "Yojana Gadiya"
SET DOCUMENT ContactInfo = "yojana.gadiya@scai.fraunhofer.de"
SET DOCUMENT Description = "The Origin, Transmission and Clinical Therapies on Coronavirus Disease \
2019 (COVID-19) Outbreak - An Update on the Status"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright © 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"

##################################################################################
# NAMESPACES Section
##################################################################################

# DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"

# DEFINE NAMESPACE ADO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns"
# DEFINE NAMESPACE BRCO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns"
# DEFINE NAMESPACE NIFT AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/nift/NIFT.belns"

DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
# DEFINE NAMESPACE MGI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns"
# DEFINE NAMESPACE RGD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20190128.belns"
# DEFINE NAMESPACE GFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc-gene-families/hgnc-genefamily-names-20181221.belns"
# DEFINE NAMESPACE SCOMP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20190128.belns"
# DEFINE NAMESPACE SFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20190128.belns"
# DEFINE NAMESPACE HP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
# DEFINE NAMESPACE DRUGBANK AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns"
# DEFINE NAMESPACE INTERPRO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-names-20181021.belns"
DEFINE NAMESPACE PFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns"
DEFINE NAMESPACE DO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns"
# DEFINE NAMESPACE GO AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns"
DEFINE NAMESPACE GOBP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20190128.belns"
# DEFINE NAMESPACE GOCC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20190128.belns"

DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"

# DEFINE NAMESPACE MESHC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20190128.belns"
# DEFINE NAMESPACE MESHD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20190128.belns"
# DEFINE NAMESPACE MESHPP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20190128.belns"
# DEFINE NAMESPACE MESHA AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-anatomy/mesh-anatomy-20190128.belns"
# DEFINE NAMESPACE MESHCS AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cellular-structures/mesh-cellular-structures-20190128.belns"
# DEFINE NAMESPACE NCBITAXON AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

DEFINE NAMESPACE NCBIGENE AS PATTERN ".*"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
# DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"
# DEFINE NAMESPACE dbSNP AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE FIXME AS PATTERN ".*"

##################################################################################
# ANNOTATIONS Section
##################################################################################

# DEFINE ANNOTATION Anatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20190128.belanno"
# DEFINE ANNOTATION CellLine AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno"
# DEFINE ANNOTATION Cell AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20190128.belanno"
# DEFINE ANNOTATION Disease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20190128.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno"
# DEFINE ANNOTATION MeSHDisease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno"
# DEFINE ANNOTATION Species AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
# DEFINE ANNOTATION TextLocation AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
# DEFINE ANNOTATION BioAssay AS PATTERN ".*"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"

# --------------------------------------------------------------------------------

##############
# Statements #
##############
SET Citation = {"PubMed", "32169119"}

SET Evidence = "Another recent research suggested [23]that the mutation in NSP2 and NSP3 play a role in infectious capability and differentiation mechanism of SARS-CoV-2."
p(FIXME:sarsnsp2,var("?")) -- path(DO:"COVID-19")
p(FIXME:sarsnsp2,var("?")) -- path(FIXME:"SARS-CoV-2 infection")
p(FIXME:sarsnsp3,var("?")) -- path(DO:"COVID-19")
p(FIXME:sarsnsp3,var("?")) -- path(FIXME:"SARS-CoV-2 infection")

SET Evidence = " S glycoprotein includes two sub-units, S1 and S2 [30]. S1 determines the virus-host range and cellular tropism with the key function domain−RBD, while S2 mediates virus-cell membrane fusion by two tandem domains, heptad repeats 1 (HR1) [31] and HR2[32]."
p(UNIPROT:P0DTC2) hasMembers list(p(FIXME:s1), p(FIXME:s2))
p(FIXME:s1) reg path(MESH:"Host Specificity")
p(FIXME:s1) reg bp(GOBP:tropism)
p(FIXME:s2) reg bp(GOBP:"membrane fusion involved in viral entry into host cell")

SET Evidence = "But in the severe patients, the neutrophil count, D-dimer, blood urea, and creatinine levels were higher significantly, and the lymphocyte counts continued to decrease."
path(DO:"COVID-19") pos a(MESH:Neutrophils)
path(DO:"COVID-19") pos a(MESH:"Blood Urea Nitrogen")
path(DO:"COVID-19") pos a(CHEBI:creatinine)
path(DO:"COVID-19") neg path(MESH:"Lymphocyte Count")

SET Evidence = "Additionally, inflammatory factors (interleukin (IL)-6, IL-10, tumor necrosis factor-α(TNF-α) increase, indicating the immune status of patients. The data showed that ICU patients had higher plasma levels of IL-2, IL-7, IL-10, granulocyte colony-stimulating factor (GCSF), 10 kD interferon-gamma-induced  protein  (IP-10),  monocyte  chemo-attractant protein-1 (MCP-1), macrophage inflammatory protein 1-α(MIP-1α), and TNF-α[48]."
#CSF3 - GCSF, CXCL10 - IP-10, CCL2 - MCP-1, CCL3 - MIP-1-alpha
path(DO:"COVID-19") pos p(HGNC:IL6)
path(DO:"COVID-19") pos p(HGNC:IL10)
path(DO:"COVID-19") pos p(HGNC:TNF)
SET MeSHAnatomy = "Plasma"
path(DO:"COVID-19") pos p(HGNC:IL2)
path(DO:"COVID-19") pos p(HGNC:IL7)
path(DO:"COVID-19") pos p(HGNC:CSF3)
path(DO:"COVID-19") pos p(HGNC:CXCL10)
path(DO:"COVID-19") pos p(HGNC:CCL2)
path(DO:"COVID-19") pos p(HGNC:CCL3)
path(DO:"COVID-19") pos p(HGNC:IL10)
path(DO:"COVID-19") pos p(HGNC:TNF)
UNSET MeSHAnatomy

SET Evidence = "Usually, Toll-like receptor (TLR) 3, TLR7, TLR8, and TLR9 sense viral RNA and DNA in the endosome [60, 61]. The viral RNA receptor retinoic-acid inducible gene I (RIG-I) [62], cytosolic receptor melanoma differentiation-associated gene 5 (MDA5) and nucleotidyl transferase cyclic GMP-AMP synthase (cGAS) [63] are responsible for the recognition of viral RNA and DNA in the cytoplasm."
#DDX58 - RIG-I, IFIH1 - MDA5
SET MeSHAnatomy = "Endosomes"
p(HGNC:TLR3) pos bp(GOBP:"detection of virus")
p(HGNC:TLR7) pos bp(GOBP:"detection of virus")
p(HGNC:TLR8) pos bp(GOBP:"detection of virus")
p(HGNC:TLR9) pos bp(GOBP:"detection of virus")
UNSET MeSHAnatomy
SET MeSHAnatomy = "Cytoplasm"
p(HGNC:DDX58) pos bp(GOBP:"detection of virus")
p(HGNC:IFIH1) pos bp(GOBP:"detection of virus")
p(HGNC:CGAS) pos bp(GOBP:"detection of virus")
UNSET MeSHAnatomy

SET Evidence = "These complex signalling recruit adaptors, including TIR-domain-containing adaptor protein including IFN-β (TRIF), mitochondrial antiviral-signalling protein (MAVS) [64] and stimulator of interferon genes protein (STING) [65] to trigger downstream cascades molecules, involving adaptor molecule MyD88 and lead to the activation of the transcription factor nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3) and the production of type I Interferons (IFN-α /β) and a series of pro-inflammatory cytokines [66]."
#these complex - above mentioned complexes
#TICAM1 - TRIF, 340061 - STING
p(HGNC:TLR3) -> p(HGNC:TICAM1)
p(HGNC:TLR3) -> p(HGNC:MAVS)
p(HGNC:TLR3) -> p(NCBIGENE:340061)
p(HGNC:TLR7) -> p(HGNC:TICAM1)
p(HGNC:TLR7) -> p(HGNC:MAVS)
p(HGNC:TLR7) -> p(NCBIGENE:340061)
p(HGNC:TLR8) -> p(HGNC:TICAM1)
p(HGNC:TLR8) -> p(HGNC:MAVS)
p(HGNC:TLR8) -> p(NCBIGENE:340061)
p(HGNC:TLR9) -> p(HGNC:TICAM1)
p(HGNC:TLR9) -> p(HGNC:MAVS)
p(HGNC:TLR9) -> p(NCBIGENE:340061)
p(HGNC:DDX58) -> p(HGNC:TICAM1)
p(HGNC:DDX58) -> p(HGNC:MAVS)
p(HGNC:DDX58) -> p(NCBIGENE:340061)
p(HGNC:IFIH1) -> p(HGNC:TICAM1)
p(HGNC:IFIH1) -> p(HGNC:MAVS)
p(HGNC:IFIH1) -> p(NCBIGENE:340061)
p(HGNC:CGAS) -> p(HGNC:TICAM1)
p(HGNC:CGAS) -> p(HGNC:MAVS)
p(HGNC:CGAS) -> p(NCBIGENE:340061)
p(HGNC:TICAM1) -> p(HGNC:MYD88)
p(HGNC:MAVS) -> p(HGNC:MYD88)
p(NCBIGENE:340061) -> p(HGNC:MYD88)
p(HGNC:MYD88) -> act(p(PFAM:NKAP),ma(tscript))
p(HGNC:MYD88) -> act(p(HGNC:IRF3))
p(HGNC:MYD88) -> act(p(MESH:"Interferon Type I"))
# p(HGNC:MYD88) -> act(a(MESH:Cytokines))
# act(a(MESH:Cytokines)) pos bp(GOBP:"inflammatory response")

SET Evidence = "Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of TNF-α and IL-6. It also works as a novel class of autophagy inhibitor [81], which may interfere with viral infection and replication."
a(CHEBI:chloroquine) -| p(HGNC:IL6)
a(CHEBI:chloroquine) -| p(HGNC:TNF)
a(CHEBI:chloroquine) -| bp(GOBP:autophagy)
bp(GOBP:autophagy) -- path(MESH:"Virus Replication")
bp(GOBP:autophagy) -- path(MESH:"Virus Diseases")

SET Evidence = "The other antiviral drugs include nitazoxanide, favipiravir, nafamostat, and so on (See Table 1 for details)."
#table 1
a(CHEBI:nafamostat) -| p(HGNC:CTSB)
p(HGNC:CTSB) pos bp(GOBP:"membrane fusion involved in viral entry into host cell")
a(CHEBI:nafamostat) neg bp(GOBP:"membrane fusion involved in viral entry into host cell")
a(CHEBI:nafamostat) -| bp(GOBP:coagulation)
a(CHEBI:oseltamivir) -| act(p(PFAM:Neur))
a(CHEBI:oseltamivir) -| bp(GOBP:"viral release from host cell")
a(CHEBI:oseltamivir) -| path(MESH:"Virus Replication")
a(CHEBI:oseltamivir) -| path(MESH:"Virus Diseases")
a(CHEBI:favipiravir) -| path(MESH:"Virus Replication")
